CHRISTUS Louisiana Surgical Hospital
651 N Bolton Ave, Alexandria, LA · Christushealth · · NPI 1164750840
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $69.93 – $187.48 | 6 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $12.41 – $12.41 | 1 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,529,026.20 – $8,293,211.57 | 5 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $3.23 – $8.97 | 2 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $59.98 – $160.81 | 6 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $27.28 – $27.28 | 1 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $27.28 – $183.54 | 6 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.41 – $3.78 | 6 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $4.93 – $11.59 | 5 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $16.64 – $16.64 | 1 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $73.37 – $196.69 | 6 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $12.71 – $33.58 | 5 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.38 – $6.37 | 6 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $80.56 – $195.41 | 2 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.13 – $0.35 | 6 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $460.77 – $1,235.23 | 6 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $360.84 – $1,990.12 | 8 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $41.04 – $41.04 | 1 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $1.57 – $1.57 | 1 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $132.04 – $444.17 | 5 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $189.01 – $444.17 | 5 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.00 – $32.19 | 6 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $46.88 – $125.67 | 6 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.93 – $5.62 | 6 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.33 – $6.24 | 6 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.41 – $3.78 | 6 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $1.52 – $3.52 | 2 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $90.13 – $90.13 | 1 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $27.96 – $78.24 | 6 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.27 – $3.39 | 6 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.74 – $0.74 | 1 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $20.91 – $56.05 | 6 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $26.82 – $65.19 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $0.11 | 2 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $3.63 – $9.74 | 6 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $4.89 – $13.10 | 6 |
| Inj, lidocaine w epinephrine HCPCS J2004 | not published | not published | $0.01 – $0.01 | 1 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $6.97 – $21.09 | 2 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,037,245.46 – $7,137,526.83 | 5 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $302.50 – $810.92 | 6 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $22.25 – $52.29 | 5 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,018.44 – $7,093.33 | 5 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $3.38 – $3.38 | 1 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $127.17 – $340.92 | 6 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $513.00 – $513.00 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $736.05 – $1,973.19 | 6 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $234.50 – $234.50 | 1 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $3.99 – $9.06 | 2 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.30 – $5.29 | 2 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.00 – $4.70 | 5 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $1.57 – $4.22 | 6 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.27 – $1.27 | 1 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.34 – $0.79 | 2 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $33.19 – $115.75 | 6 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $231.45 – $620.46 | 6 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $23.99 – $64.31 | 6 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $9.43 – $22.05 | 2 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $7.81 – $15.72 | 2 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.99 – $4.57 | 2 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.34 – $1.05 | 2 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $10.13 – $22.19 | 2 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $610.96 – $1,637.84 | 6 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $1.57 – $4.84 | 5 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $90.24 – $241.92 | 6 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $483.29 – $4,089.00 | 8 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $483.29 – $4,089.00 | 8 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $1,066.68 – $1,066.68 | 1 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $46.07 – $106.09 | 2 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $49.31 – $132.19 | 6 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $53.05 – $53.05 | 1 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $1.26 – $2.96 | 5 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $362.97 – $973.03 | 6 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $3.76 – $8.84 | 5 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $3.73 – $9.99 | 6 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,286,218.03 – $5,372,612.37 | 5 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $25.08 – $67.24 | 6 |
| Inj, pafolacianine, 0.1 mg HCPCS A9603 | not published | not published | $143.44 – $143.44 | 1 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $56.83 – $133.55 | 5 |
| Inj pantoprazole(hikma) 40mg HCPCS J2471 | not published | not published | $7.02 – $7.02 | 1 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $65.73 – $176.20 | 6 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $507.48 – $1,192.58 | 5 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $94.01 – $252.02 | 6 |
| Inj, pedmark, 100 mg HCPCS J0208 | not published | not published | $91.32 – $214.60 | 5 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $139.23 – $373.24 | 6 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $21.98 – $351.71 | 6 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $35.68 – $83.85 | 5 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $50.13 – $134.37 | 6 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.26 – $21.76 | 5 |
| Inj, pemetrexed (avyxa) 10mg HCPCS J9292 | not published | not published | $85.32 – $85.32 | 1 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $10.04 – $23.59 | 5 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $2.44 – $6.54 | 6 |
| Inj pemetrexed (sandoz) 10mg HCPCS J9297 | not published | not published | $1.91 – $3.90 | 2 |
| Inj pemetrexed (teva) 10mg HCPCS J9314 | not published | not published | $6.79 – $18.19 | 6 |
| Inj, pemivibart, 4500 mg HCPCS Q0224 | not published | not published | $16,787.93 – $16,787.93 | 1 |
| Inj, pemrydi rtu, 10 mg HCPCS J9324 | not published | not published | $78.13 – $209.44 | 6 |
| Inj perflexane lip micros,ml HCPCS Q9955 | not published | not published | $15.39 – $15.39 | 1 |
| Inj., perseris, 0.5 mg HCPCS J2798 | not published | not published | $11.60 – $31.08 | 6 |
| Inj plasminogen tvmh 1mg HCPCS J2998 | not published | not published | $30.93 – $72.69 | 5 |
| Inj., plazomicin, 5 mg HCPCS J0291 | not published | not published | $3.40 – $9.11 | 6 |
| Inj pozelimab-bbfg, 1 mg HCPCS J9376 | not published | not published | $93.47 – $93.47 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.